JP2022521273A5 - - Google Patents
Info
- Publication number
- JP2022521273A5 JP2022521273A5 JP2021549187A JP2021549187A JP2022521273A5 JP 2022521273 A5 JP2022521273 A5 JP 2022521273A5 JP 2021549187 A JP2021549187 A JP 2021549187A JP 2021549187 A JP2021549187 A JP 2021549187A JP 2022521273 A5 JP2022521273 A5 JP 2022521273A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- subject
- composition
- eye
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962808037P | 2019-02-20 | 2019-02-20 | |
| US62/808,037 | 2019-02-20 | ||
| PCT/US2020/018808 WO2020172260A1 (en) | 2019-02-20 | 2020-02-19 | Topical composition for improved healing of ocular ailments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521273A JP2022521273A (ja) | 2022-04-06 |
| JP2022521273A5 true JP2022521273A5 (https=) | 2023-03-23 |
Family
ID=72143642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549187A Pending JP2022521273A (ja) | 2019-02-20 | 2020-02-19 | 眼の病気の治癒の改善のための局所用組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210379161A1 (https=) |
| EP (1) | EP3927369A4 (https=) |
| JP (1) | JP2022521273A (https=) |
| AU (1) | AU2020224106A1 (https=) |
| CA (1) | CA3130937A1 (https=) |
| IL (1) | IL285705A (https=) |
| MA (1) | MA55038A (https=) |
| MX (1) | MX2021010088A (https=) |
| WO (1) | WO2020172260A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2203500C2 (ru) * | 2000-10-20 | 2003-04-27 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Способ диагностики ранних стадий диабетической ретинопатии |
| WO2010097800A1 (en) * | 2009-02-26 | 2010-09-02 | Muhammad Abdulrazik | Synergistic combination of bioactive compounds for lowering of intraocular pressure |
| US20110294730A1 (en) * | 2010-05-31 | 2011-12-01 | Shantha Totada R | Method of treating glaucoma and intraocular hypertension |
| US20120003296A1 (en) * | 2010-07-01 | 2012-01-05 | Shantha Totada R | New methods of treating dry eye syndrome |
| AU2011327785A1 (en) * | 2010-11-08 | 2013-03-07 | Healor Ltd. | Buffered ophthalmic compositions and methods of use thereof |
| US20160220581A1 (en) * | 2015-01-30 | 2016-08-04 | Jds Therapeutics, Llc | Chromium compositions for the treatment or prevention of diabetic retinopathy |
-
2020
- 2020-02-19 MX MX2021010088A patent/MX2021010088A/es unknown
- 2020-02-19 MA MA055038A patent/MA55038A/fr unknown
- 2020-02-19 WO PCT/US2020/018808 patent/WO2020172260A1/en not_active Ceased
- 2020-02-19 JP JP2021549187A patent/JP2022521273A/ja active Pending
- 2020-02-19 AU AU2020224106A patent/AU2020224106A1/en not_active Abandoned
- 2020-02-19 US US17/431,936 patent/US20210379161A1/en not_active Abandoned
- 2020-02-19 EP EP20759637.0A patent/EP3927369A4/en not_active Withdrawn
- 2020-02-19 CA CA3130937A patent/CA3130937A1/en active Pending
-
2021
- 2021-08-18 IL IL285705A patent/IL285705A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2323642B1 (en) | Use of EDTA+tromethamine or of photoenhancers, associated to riboflavin for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders | |
| CA2718161C (en) | Drug delivery to the anterior and posterior segments of the eye using eye drops | |
| CN105848651B (zh) | 干眼症治疗用滴眼剂 | |
| Yang et al. | Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma | |
| US9155745B2 (en) | Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs | |
| WO2010027743A1 (en) | Pharmaceutical compositions and methods for the treatment of dry eye | |
| US20060293270A1 (en) | Methods and compositions for treating ocular disorders | |
| JP2021522180A5 (https=) | ||
| JPH0114204B2 (https=) | ||
| TR201808687T4 (tr) | Düşük vi̇zkozi̇teli̇ gli̇kosami̇nogli̇kanlardan oluşan bi̇leşi̇mler ve söz konusu bi̇leşi̇mi̇n, kroni̇k si̇sti̇t tedavi̇si̇nde kullanimi | |
| JP2022521273A5 (https=) | ||
| EP3474836B1 (en) | Salbutamol-containing ophthalmic medicament | |
| RU2581495C1 (ru) | Способ лечения синдрома сухого глаза | |
| JP7615139B2 (ja) | 萎縮型加齢黄斑変性（ａｍｄ）又は萎縮型ａｍｄに続発する地図状委縮の治療用抗ｃ５剤 | |
| KR20220062279A (ko) | 안질환의 치료 방법 | |
| TW202128746A (zh) | 融合蛋白在治療年齡相關性黃斑變性中的應用 | |
| EP2870971B1 (en) | Drug for preventing/treating ocular disease | |
| Noble et al. | Retinal vascular remodelling in radiation retinopathy. | |
| JP2018099117A (ja) | Ｃａｓｐ２に対する二本鎖ｒｎａ化合物およびその使用 | |
| JP5791064B2 (ja) | 医薬用組成物 | |
| CN109789182A (zh) | 治疗干眼综合征的方法 | |
| WO2024152648A1 (zh) | Bet蛋白降解剂在预防和治疗视网膜退行性改变相关疾病中的应用 | |
| JP2006523461A (ja) | 羊ヒアルロニダーゼを単離し精製する方法 | |
| RU2314102C1 (ru) | Способ комплексного лечения дисфункции мейбомиевых желез | |
| Kogure et al. | Efficacy and retention times of intravitreal triamcinolone acetonide for macular edema |